Trials / Terminated
TerminatedNCT00970424
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus on Background Treatment With Pioglitazone
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 252 (actual)
- Sponsor
- Forest Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of dutogliptin in patients with type 2 diabetes mellitus (T2DM) who are receiving background treatment with pioglitazone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | placebo, oral tablet administered once daily on background of pioglitazone |
| DRUG | Dutogliptin | dutogliptin, oral tablet administered once daily on background of pioglitazone |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2010-08-01
- First posted
- 2009-09-02
- Last updated
- 2011-09-21
Locations
118 sites across 6 countries: United States, Belarus, Germany, India, Lithuania, Romania
Source: ClinicalTrials.gov record NCT00970424. Inclusion in this directory is not an endorsement.